S Science Co. Ltd. (TSE:5721) announced a third-party allotment agreement for a private placement of 250,000 units of the 6th stock acquisition rights at an issue price of ¥11 per stock acquisition right for gross proceeds of ¥2,750,000 on March 5, 2021. The transaction will involve participation from Evo Fund, a fund managed by Evolution Capital Management, LLC. The stock acquisition right may be converted into 25,000,000 shares (100 shares per stock acquisition right), with initial exercise price of the amount equivalent to 90% of the condition determination standard stock price rounded up to the nearest ¥0.1, which is set at ¥21.5 and no maximum exercise price. The company will raise ¥970,250,000 on exercise of security. The company will pay issuance expenses of ¥8,000,000 and will receive net proceeds on ¥962,250,000 on exercise of security. The period during which the stock acquisition rights can be exercised from March 30, 2021 to April 26, 2022. The allotment date is March 29, 2021. The transaction is approved by the board of directors of the company.